• Home
  • Batavia Biosciences

Batavia Biosciences

About Batavia Biosciences

Batavia Biosciences significantly contributes to ease human suffering from infectious diseases and cancer by leveraging our innovative technologies and in-depth know-how at all stages of the development trajectory, from the transition into early clinical studies, to navigating late-stage clinical development and entering commercial manufacturing at higher speed, reduced costs, and with inc...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Netherlands
  • On CPHI since:
    2019
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
Show contact info Hide contact info

Products from Batavia Biosciences (1)

  • HIP-Vax

    Product HIP-Vax

    The demand for viral vector-based products is growing rapidly. However, there are still manufacturing challenges which hamper the development of these promising new therapies. A major problem is low product yields. For many medical applications, a certain minimal dose of product is needed to have a clinica...

Batavia Biosciences Resources (1)

  • Batavia enters the commercial manufacturing business

    News Batavia enters the commercial manufacturing business

    Batavia Biosciences announces that it will extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services. The company has finalized the design plans of its new 12.000 square meter building to be realized at the Bioscience Park in Leiden, The Netherlands. It is expected that the manufacturing facility will be operational around Q3- 2024.
    7 Sep 2022